Team:Westminster/Parts

From 2012.igem.org

(Difference between revisions)
Line 1: Line 1:
-
<!--- The Mission, Experiments --->
 
-
 
<html>
<html>
 +
<head>
<head>
-
<style type="text/css">
+
 
-
body {
+
<meta http-equiv="content-type" content="text/php; charset=utf-8" />
-
    background: url("http://www.westminsterigem.com/files/theme/body-bg.png") repeat #ffffff
+
 
-
}
+
<style type="text/css">
-
a {
+
@import url 'http://yui.yahooapis.com/2.9.0/build/reset/reset-min.css';
-
    color: #66c9c1;
+
ul {
-
}
+
list-style: none;
-
a:visited, td a:visited {
+
}
-
    background: #ffeebb !important;
+
body {
-
}  
+
font-family: "HelveticaNeue-Light", "Helvetica Neue Light", "Helvetica Neue", Helvetica, Arial, "Lucida Grande", sans-serif;  
-
table, p {
+
font-weight: 300;
-
    font-family: "HelveticaNeue-Light", "Helvetica Neue Light", "Helvetica Neue", Helvetica, Arial, "Lucida Grande", sans-serif;  
+
background: url("http://www.westminsterigem.com/files/theme/body-bg.png") repeat #ffffff;
-
    font-weight: 300;
+
color: #666666;
-
    font-size: 11pt;
+
}
-
    color: #666666;
+
h1, h2 {
-
}
+
color: #ff0000;
-
div#globalWrapper > div {
+
font-size: 18pt;
-
    box-shadow: 0 0 17px -4px #666666;
+
margin-bottom: 0.5em;
-
}
+
}
-
div#content {
+
h2 {
-
    width: 945px;
+
font-size: 16pt;
-
    padding: 15px;
+
}
-
}
+
h3 {
-
ul#navigation {
+
color: #ff0000;
-
    list-style: none;
+
}
-
    overflow: auto;
+
p {
-
}
+
 
-
ul#navigation > li {
+
}
-
    background: url("http://www.westminsterigem.com/files/theme/nav-sep.png") no-repeat scroll right 10px transparent;
+
a {
-
    float: left;
+
-
    height: 25px;
+
}
-
    padding: 0px 15px;
+
#p-logo {
-
}
+
background: #444444;
-
ul#navigation > li.first-item {
+
}
-
    padding-left: 0px;
+
div#top-section,
-
}
+
div#content {
-
ul#navigation > li.last-item {
+
box-shadow: 0px 0px 17px -4px #666666;
-
    background: none;
+
}
-
    padding-right: 0px;
+
div#wrapper {
-
}
+
position: relative;
-
ul#navigation a.navlink {
+
width: 885px;
-
    line-height: 25px;
+
font-size: 12pt;
-
    list-style: none outside none;
+
padding: 50px 40px;
-
    color: #545454;
+
margin: 0 auto;
-
    border-top: 3px solid transparent;
+
background: #ffffff;
-
    padding: 3px 15px;
+
}
-
}
+
div#header {
-
ul#navigation a.navlink:hover {
+
height: 185px;
-
    border-top: 3px solid #66c9c1;
+
}
-
    color: #545454;
+
div#header div#logo {
-
    text-decoration: none;
+
position: relative;
-
}
+
width: 400px;
-
div#footer-box {
+
height: 125px;
-
    border-radius: 0 0 5px 5px;
+
margin: 0 auto;
-
}
+
}
-
</style>
+
div#header div#logo {
 +
margin-bottom: 20px;
 +
}
 +
div#navigation {
 +
width: 100%;
 +
height: 40px;
 +
background: #000000;
 +
}
 +
ul#navigation-list {
 +
height: 40px;
 +
line-height: 40px;
 +
overflow: hidden;
 +
}
 +
ul#navigation-list > li {
 +
float: left;
 +
}
 +
ul#navigation-list > li > ul {
 +
position: absolute;
 +
display: none;
 +
background: #000000;
 +
z-index: 100000;
 +
}
 +
ul#navigation-list > li > ul.submenu {
 +
margin: 0;
 +
}
 +
ul#navigation-list > li > ul.submenu li {
 +
padding: 5px 0px;
 +
}
 +
ul#navigation-list a.navlink {
 +
color: #ffffff;
 +
font-weight: bold;
 +
display: block;
 +
padding: 0px 14px;
 +
text-decoration: none;
 +
}
 +
ul#navigation-list a.navlink.active,
 +
ul#navigation-list a.navlink:hover {
 +
color: #ff0000;
 +
}
 +
div#home-main-image {
 +
text-align: center;
 +
}
 +
div#home-main-image img {
 +
width: 885px;
 +
height: 300px;
 +
margin-bottom: 20px;
 +
border-radius: 20px;
 +
}
 +
div.text-box {
 +
background: #444444;
 +
color: #ffffff;
 +
padding: 15px 20px;
 +
border-radius: 10px;
 +
}
 +
div.three-columns {
 +
padding-left: 20px;
 +
overflow: auto;
 +
}
 +
div.column, img.column {
 +
float: left;
 +
width: 235px;
 +
margin: 10px 0px 50px 20px;
 +
border-radius: 10px;
 +
}
 +
div#footer-box {
 +
border-radius: 0 0 5px 5px;
 +
}
 +
</style>
 +
 
 +
<script type="text/javascript" src="http://code.jquery.com/jquery-1.8.2.min.js"></script>
 +
<script type="text/javascript">
 +
$('document').ready(function() {
 +
$('li.submenu-holder').hover(function() {
 +
$(this).children('ul.submenu').stop(true).fadeIn('slow');
 +
}, function() {
 +
$(this).children('ul.submenu').stop(true).fadeOut('slow');
 +
});
 +
});
 +
</script>
 +
 
</head>
</head>
<body>
<body>
-
<ul id="navigation">
 
-
  <li class="first-item"><a href="https://2012.igem.org/Team:Westminster" class="navlink">Home</a></li>
 
-
  <li><a href="https://2012.igem.org/Team:Westminster/Team" class="navlink">Team</a></li>
 
-
  <li><a href="https://igem.org/Team.cgi?year=2012&team_name=Westminster"class="navlink">Team Profile</a></li>
 
-
  <li><a href="https://2012.igem.org/Team:Westminster/Project"class="navlink">Project</a></li>
 
-
  <li><a href="https://2012.igem.org/Team:Westminster/Parts"class="navlink">Parts</a></li>
 
-
  <li><a href="https://2012.igem.org/Team:Westminster/Modeling"class="navlink">Modeling</a></li>
 
-
  <li><a href="https://2012.igem.org/Team:Westminster/Notebook"class="navlink">Notebook</a></li>
 
-
  <li><a href="https://2012.igem.org/Team:Westminster/Safety"class="navlink">Safety</a></li>
 
-
  <li class="last-item"><a href="https://2012.igem.org/Team:Westminster/Attributions"class="navlink">Attributions</a></li>
 
-
</ul>
 
-
</body>
 
-
</html>
 
-
An important aspect of the iGEM competition is the use and creation of standard  biological parts. Each team will make new parts during iGEM and will place them in the [http://partsregistry.org Registry of Standard Biological Parts]. The iGEM software provides an easy way to present the parts your team has created . The "groupparts" tag will generate a table with all of the parts that your team adds to your team sandbox.  Note that if you want to document a part you need to document it on the [http://partsregistry.org Registry], not on your team wiki.
+
<div id="wrapper">
-
Remember that the goal of proper part documentation is to describe and define a part such that it can be used without a need to refer to the primary literature. The next iGEM team should be able to read your documentation and be able to use the part successfully. Also, you should provide proper references to acknowledge previous authors and to provide for  users who wish to know more.
+
<div id="header">
 +
<div id="logo">
 +
<a href="https://2012.igem.org/Team:Westminster">
 +
<img src="https://static.igem.org/mediawiki/2012/1/1e/Westminster-logo.png" alt="iSTEM" title="Back to home!" />
 +
</a>
 +
</div><!-- #logo -->
 +
<div id="navigation">
 +
<ul id="navigation-list">
 +
<li><a href="https://2012.igem.org/Team:Westminster" class="navlink">Home</a></li>
 +
<li><a href="https://2012.igem.org/Team:Westminster/Team" class="navlink">Team</a></li>
 +
<li><a href="https://igem.org/Team.cgi?year=2012&team_name=Westminster"class="navlink">Team Profile</a></li>
 +
<li class="submenu-holder">
 +
<a href="https://2012.igem.org/Team:Westminster/Project/Overview"class="navlink active">Project</a>
 +
<ul class="submenu">
 +
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Overview"class="navlink active">Overview</a></li>
 +
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Problem"class="navlink">The Problem</a></li>
 +
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Experiments"class="navlink">Experiments</a></li>
 +
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Protocols"class="navlink">Protocols</a></li>
 +
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Results"class="navlink">Results</a></li>
 +
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Safety"class="navlink">Safety</a></li>
 +
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Journal"class="navlink">Journal</a></li>
 +
</ul>
 +
</li>
 +
<li><a href="https://2012.igem.org/Team:Westminster/Parts"class="navlink">Parts</a></li>
 +
<li><a href="https://2012.igem.org/Team:Westminster/Modeling"class="navlink">Modeling</a></li>
 +
<li><a href="https://2012.igem.org/Team:Westminster/Notebook"class="navlink">Notebook</a></li>
 +
<li><a href="https://2012.igem.org/Team:Westminster/Safety"class="navlink">Safety</a></li>
 +
<li><a href="https://2012.igem.org/Team:Westminster/Attributions"class="navlink">Attributions</a></li>
 +
</ul><!-- #navigation-list -->
 +
</div><!-- #navigation -->
 +
</div><!-- #header -->
 +
<div id="the-content">
 +
<div id="home-main-image">
 +
<img src="https://static.igem.org/mediawiki/2012/4/4d/Westminster_team.png" alt="Welcome" title="Welcome to our home!" />
 +
</div><!-- #home-main-image -->
-
<groupparts>iGEM012 Westminster</groupparts>
+
<div id="home-main-text">
 +
<h2>Lorem Ipsum</h2>
 +
<p>Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.</p>
 +
<img class="column" src="https://static.igem.org/mediawiki/2012/4/4d/Westminster_team.png" width="255" height="220" />
 +
<h2>Lorem Ipsum</h2>
 +
<p>Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.</p>
 +
<img class="column" src="https://static.igem.org/mediawiki/2012/4/4d/Westminster_team.png" width="255" height="220" />
 +
<h2>Lorem Ipsum</h2>
 +
<p>Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.</p>
 +
<img class="column" src="https://static.igem.org/mediawiki/2012/4/4d/Westminster_team.png" width="255" height="220" />
 +
</div><!-- #home-main-text -->
 +
 
 +
</div><!-- #the-content -->
 +
 
 +
</div><!-- #wrapper -->
 +
 
 +
 
 +
</body>
 +
 
 +
</html>

Revision as of 20:06, 25 September 2012

Welcome

Lorem Ipsum

Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.

Lorem Ipsum

Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.

Lorem Ipsum

Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.

Retrieved from "http://2012.igem.org/Team:Westminster/Parts"